Intermediation to help companies grow
Large corporate groups have come to recognize Genopole as a reliable intermediator for technology scouting, that is, the ever-growing need of these entities to find useful innovations developed in start-ups. In 2021, Genopole’s year-spanning intermediation efforts resulted in a green science co-incubation project under development at the biocluster with a large group.
Throughout the year, Genopole’s teams organized meetings between its accompanied businesses and actors in industry. For example, Genopole teamed with Choose Paris Region for an April webinar on the subject of future nutrition in Île-de-France, with the participation of Gourmey, Cearitis and WatchFrog. Another such event had been held in February as part of Bioket on the theme of new challenges and opportunities for the bioeconomy, with Ynsect, Altar and NextProtein present.
Connecting to major industrial groups
Partner4Biotech is Genopole’s flagship event for building business connections. At the entirely-digital 2021 event held 28–30 September, 40 Genopole-accompanied businesses were able to exchange with 25 major international corporations. More than 110 meetings were held between the heads of Genopole start-ups and industrials in the fields of health, cosmetics, nutrition and others. The event generated a number of opportunities for financing, industrialization, R&D, proof of concept and marketing partnerships.
A filmed roundtable held under the banner "Keys for a Successful Partnership" gave two Genopole companies (Altar and Innovhem) an opportunity to exchange with and receive advice from two major groups (Danone and Servier) on strategies for building corporate partnerships.
Watch the replayBuilding relations with investors
Genopole is also a match-maker for investors. At year 2021’s Invest4Biotech event, held 6–7 May, Genopole’s start-ups were able to pitch to then meet with close to 30 investors. Throughout the year, Genopole remained focused not only on helping its companies obtain financing but also enlarging its network of investors, particularly at international forums such as BIO or RESI (Redefining Early Stage Investment).
Watch the replay